Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
about
Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study
P2860
Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh-hant
name
Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
@en
Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
@nl
type
label
Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
@en
Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
@nl
prefLabel
Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
@en
Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
@nl
P2860
P356
P1433
P1476
Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
@en
P2093
Carr-Locke DL
P2860
P304
P356
10.1136/GUT.21.8.656
P407
P577
1980-08-01T00:00:00Z